Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Genor Biopharma Holdings Limited ( (HK:6998) ) has shared an update.
Genor Biopharma Holdings Limited announced the results of its Annual General Meeting held on June 26, 2025. All proposed resolutions, including the re-election of directors and the reappointment of Ernst & Young as auditors, were approved by shareholders. The company also received authorization for share repurchase and issuance mandates, indicating a strategic move to enhance shareholder value and operational flexibility.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative biologics. The company is listed on the Stock Exchange of Hong Kong and engages in producing therapeutic products for various medical needs.
Average Trading Volume: 1,001,468
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.34B
For an in-depth examination of 6998 stock, go to TipRanks’ Overview page.